Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
    1.
    发明授权
    Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels 有权
    霍霍巴产品的制备和施用用于降低体重,脂肪和血脂水平

    公开(公告)号:US07138134B2

    公开(公告)日:2006-11-21

    申请号:US10212577

    申请日:2002-08-05

    IPC分类号: A61K47/00 A61F13/00

    摘要: A method of orally administering jojoba for fat reduction, blood lipid reduction, and cancer prevention and treatment in humans is disclosed. The method incorporates a sufficient quantity of jojoba, defatted jojoba meal, jojoba extract, defatted jojoba meal extract, naturally derived or synthesized simmondsin, or any naturally derived or synthesized simmondsin derivative or analogue, including aglycon, or any mixture thereof into an individual's diet in the form of a food, dietary supplement, or drug to provide simmondsin component in an amount greater than 0.01% of one's total daily diet by weight, or 0.05 gram/day. The dosage amount and duration of the administration can vary to achieve and maintain one's desired body composition and blood lipid levels. The dosage and duration of administration are increased for cancer prevention and treatment.

    摘要翻译: 本发明公开了一种口服荷荷巴用于人体减脂,降血脂,预防和治疗癌症的方法。 该方法将足量的霍霍巴,脱脂霍霍巴粉,霍霍巴提取物,脱脂霍霍巴粉提取物,天然衍生或合成的simmondsin或任何天然衍生或合成的simmondsin衍生物或类似物(包括糖苷配基或其任何混合物)并入个体的饮食中 食物,膳食补充剂或药物的形式,提供辛伐他汀组分的量大于每日总重量的0.01%,或0.05克/天。 施用的剂量和持续时间可以变化以实现和维持所需的身体组成和血脂水平。 增加用于癌症预防和治疗的剂量和施用持续时间。

    Method of Manufacturing Magnoliidae Compounds
    2.
    发明申请
    Method of Manufacturing Magnoliidae Compounds 有权
    Magnoliidae化合物的制备方法

    公开(公告)号:US20110104310A1

    公开(公告)日:2011-05-05

    申请号:US12612966

    申请日:2009-11-05

    IPC分类号: A61K36/00 A61P3/04

    CPC分类号: A61K36/57

    摘要: Magnoliidae compounds are made by obtaining parts of Magnoliidae plants. The parts of the Magnoliidae plants are mixed with alcohol and water. The mixture of the parts of the Magnoliidae plants, alcohol and water is heated and the parts of the Magnoliidae plants are removed so that a liquid mixture remains. The liquid mixture is drying to form a solid composition. Alcohol and water are added to the solid composition to reconstitute the solid composition into a liquid composition. The liquid composition is heated to form solid matter. The solid matter is dried to obtain a purified composition of the Magnoliidae compounds. A dose of Magnoliidae compounds promotes weight loss and can be administered in liquid form, sublingually, intravenously, in a pharmaceutically acceptable carrier, in combination with a metabolite detoxification agent, in combination with a nutritional or dietary supplement, or in chewing gum.

    摘要翻译: Magnoliidae化合物通过获得Magnoliidae植物的部分来制备。 Magnoliidae植物的部分与酒精和水混合。 将Magnoliidae植物,酒精和水的部分混合物加热,并除去Magnoliidae植物的部分,使残留液体混合物。 将液体混合物干燥以形成固体组合物。 将醇和水加入到固体组合物中以将固体组合物重构成液体组合物。 液体组合物被加热以形成固体物质。 将固体物质干燥以获得Magnoliidae化合物的纯化组合物。 一种Magnoliidae化合物的剂量促进体重减轻,并且可以与液体形式,舌下,静脉内,药学上可接受的载体,与代谢物解毒剂,营养或膳食补充剂或口香糖组合施用。

    Method of manufacturing magnoliidae compounds
    3.
    发明授权
    Method of manufacturing magnoliidae compounds 有权
    制造Magnoliidae化合物的方法

    公开(公告)号:US09180154B2

    公开(公告)日:2015-11-10

    申请号:US12612966

    申请日:2009-11-05

    IPC分类号: A61K36/57

    CPC分类号: A61K36/57

    摘要: Magnoliidae compounds are made by obtaining parts of Magnoliidae plants. The parts of the Magnoliidae plants are mixed with alcohol and water. The mixture of the parts of the Magnoliidae plants, alcohol and water is heated and the parts of the Magnoliidae plants are removed so that a liquid mixture remains. The liquid mixture is drying to form a solid composition. Alcohol and water are added to the solid composition to reconstitute the solid composition into a liquid composition. The liquid composition is heated to form solid matter. The solid matter is dried to obtain a purified composition of the Magnoliidae compounds. A dose of Magnoliidae compounds promotes weight loss and can be administered in liquid form, sublingually, intravenously, in a pharmaceutically acceptable carrier, in combination with a metabolite detoxification agent, in combination with a nutritional or dietary supplement, or in chewing gum.

    摘要翻译: Magnoliidae化合物通过获得Magnoliidae植物的部分来制备。 Magnoliidae植物的部分与酒精和水混合。 将Magnoliidae植物,酒精和水的部分混合物加热,并除去Magnoliidae植物的部分,使残留液体混合物。 将液体混合物干燥以形成固体组合物。 将醇和水加入到固体组合物中以将固体组合物重构成液体组合物。 液体组合物被加热以形成固体物质。 将固体物质干燥以获得Magnoliidae化合物的纯化组合物。 一种Magnoliidae化合物的剂量促进体重减轻,并且可以与液体形式,舌下,静脉内,药学上可接受的载体,与代谢物解毒剂,营养或膳食补充剂或口香糖组合施用。

    Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer
    4.
    发明授权
    Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer 有权
    用于降低体重,脂肪和血脂水平以及预防和治疗癌症的霍霍巴产品的制备和施用

    公开(公告)号:US08673343B2

    公开(公告)日:2014-03-18

    申请号:US11536920

    申请日:2006-09-29

    IPC分类号: A61K47/00 A61F13/00 C08B37/00

    摘要: A method of orally administering jojoba for fat reduction, blood lipid reduction, and cancer prevention and treatment in humans is disclosed. The method incorporates a sufficient quantity of jojoba, defatted jojoba meal, jojoba extract, defatted jojoba meal extract, naturally derived or synthesized simmondsin, or any naturally derived or synthesized simmondsin derivative or analogue, including aglycon, or any mixture thereof into an individual's diet in the form of a food, dietary supplement, or drug to provide simmondsin component in an amount greater than 0.01% of one's total daily diet by weight, or 0.05 gram/day. The dosage amount and duration of the administration can vary to achieve and maintain one's desired body composition and blood lipid levels. The dosage and duration of administration are increased for cancer prevention and treatment.

    摘要翻译: 本发明公开了一种口服荷荷巴用于人体减脂,降血脂,预防和治疗癌症的方法。 该方法将足量的霍霍巴,脱脂霍霍巴粉,霍霍巴提取物,脱脂霍霍巴粉提取物,天然衍生或合成的simmondsin或任何天然衍生或合成的simmondsin衍生物或类似物(包括糖苷配基或其任何混合物)并入个体的饮食中 食物,膳食补充剂或药物的形式,提供辛伐他汀组分的量大于每日总重量的0.01%,或0.05克/天。 施用的剂量和持续时间可以变化以实现和维持所需的身体组成和血脂水平。 增加用于癌症预防和治疗的剂量和施用持续时间。